1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Blood Disorders Market, By Type
5.1 Introduction
5.2 Hemophilia A
5.3 Hemophilia B
5.4 Von Willebrand Disease
5.5 Other Types
6 Global Blood Disorders Market, By Disorder
6.1 Introduction
6.2 Genetic Haematology Disorders
6.3 Haemoglobin Disorders
6.4 Myeloproliferative Disorders
6.5 Platelet Based Disorders
6.6 Blood Cancers
6.7 Plasma Disorders
6.8 Other Disorders
7 Global Blood Disorders Market, By Treatment Type
7.1 Introduction
7.2 Drug Therapy
7.2.1 Plasma-derived Coagulation Factor Concentrates
7.2.2 Recombinant Coagulation Factor Concentrates
7.2.3 Desmopressin
7.2.4 Antifibrinolytics
7.2.5 Fibrin sealants
7.3 Factor Replacement Therapy
7.4 Hormone Replacement Therapy
7.5 Blood Transfusions
7.6 Pipeline Analysis
8 Global Blood Disorders Market, By Distribution Channel
8.1 Introduction
8.2 Drug Stores
8.3 Hospital Pharmacies
8.4 Online Pharmacies
8.5 Retail Pharmacies
9 Global Blood Disorders Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Novo Nordisk A/S
11.2 Bayer AG
11.3 Sanofi
11.4 Octapharma AG
11.5 Pfizer Inc.
11.6 Grifols International SA
11.7 Medexus Pharma, Inc.
11.8 CSL Limited
11.9 F. Hoffmann-La Roche Ltd.
11.10 Baxter International Inc.
11.11 Takeda Pharmaceutical Company Limited
11.12 Thea Laboratories
11.13 Zydus Group
11.14 Wellona Pharma
11.15 Ferring Pharmaceuticals
11.16 Novartis AG
11.17 OASIS Medical
11.18 Bausch & Lomb Incorporated
11.19 Johnson & Johnson Services Inc.
11.20 Sun Pharmaceutical Industries Limited
List of Tables
Table 1 Global Blood Disorders Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Blood Disorders Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Blood Disorders Market Outlook, By Hemophilia A (2021-2030) ($MN)
Table 4 Global Blood Disorders Market Outlook, By Hemophilia B (2021-2030) ($MN)
Table 5 Global Blood Disorders Market Outlook, By Von Willebrand Disease (2021-2030) ($MN)
Table 6 Global Blood Disorders Market Outlook, By Other Types (2021-2030) ($MN)
Table 7 Global Blood Disorders Market Outlook, By Disorder (2021-2030) ($MN)
Table 8 Global Blood Disorders Market Outlook, By Genetic Haematology Disorders (2021-2030) ($MN)
Table 9 Global Blood Disorders Market Outlook, By Haemoglobin Disorders (2021-2030) ($MN)
Table 10 Global Blood Disorders Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 11 Global Blood Disorders Market Outlook, By Platelet Based Disorders (2021-2030) ($MN)
Table 12 Global Blood Disorders Market Outlook, By Blood Cancers (2021-2030) ($MN)
Table 13 Global Blood Disorders Market Outlook, By Plasma Disorders (2021-2030) ($MN)
Table 14 Global Blood Disorders Market Outlook, By Other Disorders (2021-2030) ($MN)
Table 15 Global Blood Disorders Market Outlook, By Treatment Type (2021-2030) ($MN)
Table 16 Global Blood Disorders Market Outlook, By Drug Therapy (2021-2030) ($MN)
Table 17 Global Blood Disorders Market Outlook, By Plasma-derived Coagulation Factor Concentrates (2021-2030) ($MN)
Table 18 Global Blood Disorders Market Outlook, By Recombinant Coagulation Factor Concentrates (2021-2030) ($MN)
Table 19 Global Blood Disorders Market Outlook, By Desmopressin (2021-2030) ($MN)
Table 20 Global Blood Disorders Market Outlook, By Antifibrinolytics (2021-2030) ($MN)
Table 21 Global Blood Disorders Market Outlook, By Fibrin sealants (2021-2030) ($MN)
Table 22 Global Blood Disorders Market Outlook, By Factor Replacement Therapy (2021-2030) ($MN)
Table 23 Global Blood Disorders Market Outlook, By Hormone Replacement Therapy (2021-2030) ($MN)
Table 24 Global Blood Disorders Market Outlook, By Blood Transfusions (2021-2030) ($MN)
Table 25 Global Blood Disorders Market Outlook, By Pipeline Analysis (2021-2030) ($MN)
Table 26 Global Blood Disorders Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 27 Global Blood Disorders Market Outlook, By Drug Stores (2021-2030) ($MN)
Table 28 Global Blood Disorders Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 29 Global Blood Disorders Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
